Pharmaceutical - HMA (Cap. Enzalutamide 40mg (Xtandi))

• Country: UAE
• Summary: Pharmaceutical - HMA (Cap. Enzalutamide 40mg (Xtandi))
• AET Ref No: 51360936
• Deadline: 24 Mar 2021
• Financier: Self Financed
• Purchaser Ownership: -
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: rfq_155531
• Purchaser's Detail:

Purchaser : DUBAI HEALTH AUTHORITY
Dubai Health Authority Building, Al Maktoum Bridge Street, Bur Dubai Area 4545 Fax: +971-43113113
Email :wasselsotak@dha.gov.ae
URL :https://www.dha.gov.ae/

• Description:
• Quotation are invited for Pharmaceutical - HMA (Cap. Enzalutamide 40mg (Xtandi)). Description 1: Cap. Enzalutamide 40mg ( Xtandi ) - 112 Ea Online Response Required: Yes Closing: 24/03/2021 10:00:00 Time Limit for Expressing Interest: 24/03/2021 10:00:00 In order to participate in this RFQ/Tender, please register online on www.eSupply.dubai.gov.ae, which is the official procurement portal of Dubai Government.
• Documents:

 Tender Notice